Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1981 May;43(1):33–38.

Stabilization of homologous and heterologous cell-bound amplification convertases. C3bBb, by C3 nephritic factor

M R Daha, L A Van Es
PMCID: PMC1555189  PMID: 6166544

Abstract

C3 nephritic factor (C3NeF) may be found in the sera of patients with membranoproliferative glomerulonephritis or partial lipodystrophy. It is capable of activating the alternative pathway in normal human serum; purified C3NeF has been shown to bind to the amplification convertase of complement, C3bBb. The binding of C3NeF to C3bBb results in stabilization of the otherwise labile C3 convertase. Decay of the convertase is accompanied by release of Bi and C3NeF from C3b. To determine whether stabilization of C3bBb occurs by the binding of C3NeF to C3bBb itself, to C3b or Bb alone, homologous and heterologous cell-bound convertases were prepared with C3hu, Bhu, C3rat and Brat and exposed to C3NeF or properdin. It was found that properdin induced stabilization of C3bhuBbhu, C3bratBbhu, C3bhuBbrat and C3bratBbrat in a dose-dependent manner. On the other hand, nine out of ten C3NeF preparations were only capable of stabilizing C3bhuBbhu and C3bratBbhu and not C3bhuBbrat and C3bratBbrat. To determine whether binding of [125I]-C3NeF to the various convertases occurred, cell-bound convertase were prepared in the presence of excess Bhu and Brat, washed and further incubated with [125I]-C3NeF; the cells were then washed and the amount of cell-bound [125I]-C3NeF was measured. As in the stabilization experiments C3NeF bound only to C3huBbhu and C3bratBbhu. The binding of C3NeF was always directly related to the presence of Bbhu in the convertase. The results obtained with nine out of ten C3NeF preparations suggest that C3NeF is an autoantibody directed against antigenic determinants on Bbhu, which are exposed after interaction of Bbhu with C3bhu or C3brat. One out of ten C3NeF preparations showed reactivity with both cell-bound C3b alone and cell-bound C3bBb. These reactivities could be separated by absorption with cell-bound C3bhu.

Full text

PDF
38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daha M. R., Austen K. F., Fearon D. T. Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol. 1978 Apr;120(4):1389–1394. [PubMed] [Google Scholar]
  2. Daha M. R., Austen K. F., Fearon D. T. The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function. J Immunol. 1977 Sep;119(3):812–817. [PubMed] [Google Scholar]
  3. Daha M. R., Fearon D. T., Austen K. F. C3 requirements for formation of alternative pathway C5 convertase. J Immunol. 1976 Aug;117(2):630–634. [PubMed] [Google Scholar]
  4. Daha M. R., Hazevoet H. M., Vanes L. A., Cats A. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus. Immunology. 1980 Jul;40(3):417–424. [PMC free article] [PubMed] [Google Scholar]
  5. Daha M. R., van Es L. A. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase. J Immunol. 1979 Mar;122(3):801–805. [PubMed] [Google Scholar]
  6. Daha M. R., van Es L. A. Further evidence for the antibody nature of C3 nephritic factor (C3NeF). J Immunol. 1979 Aug;123(2):755–758. [PubMed] [Google Scholar]
  7. Daha M. R., van Es L. A. Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3. Immunology. 1980 Dec;41(4):849–855. [PMC free article] [PubMed] [Google Scholar]
  8. Fearon D. T., Austen K. F. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med. 1975 Oct 1;142(4):856–863. doi: 10.1084/jem.142.4.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Halbwachs L., Leveillé M., Lesavre P., Wattel S., Leibowitch J. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. J Clin Invest. 1980 Jun;65(6):1249–1256. doi: 10.1172/JCI109787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hunsicker L. G., Ruddy S., Austen K. F. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol. 1973 Jan;110(1):128–138. [PubMed] [Google Scholar]
  11. Schreiber R. D., Götze O., Müller-Eberhard H. J. Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway. Scand J Immunol. 1976;5(6-7):705–713. doi: 10.1111/j.1365-3083.1976.tb03020.x. [DOI] [PubMed] [Google Scholar]
  12. Scott D. M., Amos N., Sissons J. G., Lachmann P. J., Peters D. K. The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol. 1978 Apr;32(1):12–24. [PMC free article] [PubMed] [Google Scholar]
  13. Spitzer R. E., Vallota E. H., Forristal J., Sudora E., Stitzel A., Davis N. C., West C. D. Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969 Apr 25;164(3878):436–437. doi: 10.1126/science.164.3878.436. [DOI] [PubMed] [Google Scholar]
  14. Tack B. D., Prahl J. W. Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 1976 Oct 5;15(20):4513–4521. doi: 10.1021/bi00665a028. [DOI] [PubMed] [Google Scholar]
  15. Thorell J. I., Larsson I. Lactoperoxidase coupled to polyacrylamide for radio-iodination of proteins to high specific activity. Immunochemistry. 1974 Apr;11(4):203–206. doi: 10.1016/0019-2791(74)90329-2. [DOI] [PubMed] [Google Scholar]
  16. Vallota E. H., Götze O., Spiegelberg H. L., Forristal J., West C. D., Müller-Eberhard H. J. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement. J Exp Med. 1974 May 1;139(5):1249–1261. doi: 10.1084/jem.139.5.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Weiler J. M., Daha M. R., Austen K. F., Fearon D. T. Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268–3272. doi: 10.1073/pnas.73.9.3268. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES